Decoy Therapeutics Inc. (DCOY)

US · Healthcare · Biotechnology

$1.17-4.88%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-2.4M

EPS

$-4.46

Market cap

$3.0M

P/E

0.1

Forward P/E

0.0

P/B

0.47

Book value

$8.12

EPS (TTM)

$12.74

52-week high

$54.00

52-week low

$1.15

50-day MA

$2.91

200-day MA

$6.06

Beta

0.64

Analysts rate Decoy Therapeutics Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.00.

Insiders

10.44%

Institutions

9.67%

Fund	Stake
Vanguard Capital Management, LLC	0.76%
Tower Research Capital LLC	0.05%
UBS Group AG	0.00%
Caitong International Asset Management Co., Limited.	0.00%
Danske Bank A/S.	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Advisory Services Network, LLC	0.00%
Warberg Asset Management LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Decoy Therapeutics Inc. — free to start.

Data updated 2026-10-19.